Perseus Proteomics Inc.JP:4882
| Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
---|
Cash and deposits | - | - | - | - | - | 2,445 | 1,541 |
---|
Accounts receivable - trade | - | - | - | - | - | 10 | 14 |
---|
Finished goods | - | - | - | - | - | 1 | 1 |
---|
Supplies | - | - | - | - | - | 2 | 3 |
---|
Advance payments to suppliers | - | - | - | - | - | 8 | 3 |
---|
Prepaid expenses | - | - | - | - | - | 7 | 5 |
---|
Consumption taxes refund receivable | - | - | - | - | - | 42 | 70 |
---|
Other | - | - | - | - | - | 0 | 13 |
---|
Current assets | - | - | - | - | - | 2,515 | 1,651 |
---|
Buildings | - | - | - | - | - | 11 | 1 |
---|
Accumulated depreciation | - | - | - | - | - | -11 | -1 |
---|
Buildings, net | - | - | - | - | - | - | - |
---|
Tools, furniture and fixtures | - | - | - | - | - | 114 | 92 |
---|
Accumulated depreciation | - | - | - | - | - | -114 | -92 |
---|
Tools, furniture and fixtures, net | - | - | - | - | - | - | - |
---|
Property, plant and equipment | - | - | - | - | - | - | - |
---|
Other | - | - | - | - | - | - | - |
---|
Intangible assets | - | - | - | - | - | - | - |
---|
Long-term prepaid expenses | - | - | - | - | - | - | - |
---|
Other | - | - | - | - | - | 52 | 43 |
---|
Investments and other assets | - | - | - | - | - | 52 | 43 |
---|
Non-current assets | - | - | - | - | - | 52 | 43 |
---|
Assets | - | - | - | - | - | 2,567 | 1,694 |
---|
Accounts payable - other | - | - | - | - | - | 54 | 53 |
---|
Accrued expenses | - | - | - | - | - | 29 | 57 |
---|
Income taxes payable | - | - | - | - | - | 13 | 13 |
---|
Deposits received | - | - | - | - | - | 3 | 5 |
---|
Asset retirement obligations | - | - | - | - | - | 13 | - |
---|
Current liabilities | - | - | - | - | - | 111 | 129 |
---|
Long-term deposits received | - | - | - | - | - | 59 | 166 |
---|
Non-current liabilities | - | - | - | - | - | 59 | 166 |
---|
Liabilities | - | - | - | - | - | 170 | 295 |
---|
Share capital | - | - | - | - | - | 1,939 | 1,971 |
---|
Legal capital surplus | - | - | - | - | - | 2,225 | 2,257 |
---|
Capital surplus | - | - | - | - | - | 2,225 | 2,257 |
---|
Retained earnings brought forward | - | - | - | - | - | -1,799 | -2,904 |
---|
Retained earnings | - | - | - | - | - | -1,799 | -2,904 |
---|
Treasury shares | - | - | - | - | - | -0 | -0 |
---|
Shareholders' equity | - | - | - | - | - | 2,365 | 1,324 |
---|
Share acquisition rights | - | - | - | - | - | 31 | 74 |
---|
Net assets | - | - | - | - | 3,152 | 2,397 | 1,398 |
---|
Liabilities and net assets | - | - | - | - | - | 2,567 | 1,694 |
---|